A Trial of Radiotherapy and Durvalumab in DLBCL and FL

NCT03610061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Follicular Lymphoma

Interventions

DRUG: Durvalumab
RADIATION: Radiotherapy
RADIATION: Radiotherapy (cohort 6 only)

Sponsor

Austin Health

Collaborators

[object Object]
[object Object]